<VariationArchive VariationID="617759" VariationName="NM_001242882.2(NAXD):c.54_57del (p.Ala20fs)" VariationType="Deletion" Accession="VCV000617759" Version="12" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-07-23" DateCreated="2019-02-18" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="609157" VariationID="617759">
      <GeneList>
        <Gene Symbol="NAXD" FullName="NAD(P)HX dehydratase" GeneID="55739" HGNC_ID="HGNC:25576" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q34</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="110615460" stop="110639996" display_start="110615460" display_stop="110639996" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="111267806" stop="111292342" display_start="111267806" display_stop="111292342" Strand="+" />
          </Location>
          <OMIM>615910</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001242882.2(NAXD):c.54_57del (p.Ala20fs)</Name>
      <CanonicalSPDI>NC_000013.11:110622219:AGAAAGA:AGA</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q34</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="110622220" stop="110622223" display_start="110622220" display_stop="110622223" variantLength="4" positionVCF="110622219" referenceAlleleVCF="TAGAA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="111274567" stop="111274570" display_start="111274567" display_stop="111274570" variantLength="4" positionVCF="111274566" referenceAlleleVCF="TAGAA" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>A20fs</ProteinChange>
      <ProteinChange>A38fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.111274570_111274573del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.111274570_111274573del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.110622223_110622226del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.110622223_110622226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242881.2" sequenceAccession="NM_001242881" sequenceVersion="2" change="c.108_111del">
            <Expression>NM_001242881.2:c.108_111del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229810.1" sequenceAccession="NP_001229810" sequenceVersion="1" change="p.Ala38fs">
            <Expression>NP_001229810.1:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242882.2" sequenceAccession="NM_001242882" sequenceVersion="2" change="c.54_57del" MANESelect="true">
            <Expression>NM_001242882.2:c.54_57del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001229811.1" sequenceAccession="NP_001229811" sequenceVersion="1" change="p.Ala20fs">
            <Expression>NP_001229811.1:p.Ala20fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018210.4" sequenceAccession="NM_018210" sequenceVersion="4" change="c.108_111del">
            <Expression>NM_018210.4:c.108_111del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_060680.2" sequenceAccession="NP_060680" sequenceVersion="2" change="p.Ala38fs">
            <Expression>NP_060680.2:p.Ala38fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040103.1" sequenceAccession="NR_040103" sequenceVersion="1" change="n.196_199del">
            <Expression>NR_040103.1:n.196_199del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_040104.1" sequenceAccession="NR_040104" sequenceVersion="1" change="n.196_199del">
            <Expression>NR_040104.1:n.196_199del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242883.2" sequenceAccession="NM_001242883" sequenceVersion="2" change="c.57-5216_57-5213del">
            <Expression>NM_001242883.2:c.57-5216_57-5213del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001242882.1" sequenceAccession="NM_001242882" sequenceVersion="1" change="c.54_57delAAGA">
            <Expression>NM_001242882.1:c.54_57delAAGA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018210.3" sequenceAccession="NM_018210" sequenceVersion="3" change="c.108_111delAAGA">
            <Expression>NM_018210.3:c.108_111delAAGA</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_018210.3" sequenceAccession="NM_018210" sequenceVersion="3" change="c.108_111del">
            <Expression>NM_018210.3:c.108_111del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="615910.0005" DB="OMIM" />
        <XRef Type="rs" ID="773887880" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001242882.2(NAXD):c.54_57del (p.Ala20fs) AND NAD(P)HX dehydratase deficiency" Accession="RCV000755012" Version="9">
        <ClassifiedConditionList TraitSetID="46379">
          <ClassifiedCondition DB="MedGen" ID="C5193026">NAD(P)HX dehydratase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2020-10-19" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001242882.2(NAXD):c.54_57del (p.Ala20fs) AND not provided" Accession="RCV001855857" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-09-17" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001242882.2(NAXD):c.54_57del (p.Ala20fs) AND NAXD-related disorder" Accession="RCV003965558" Version="1">
        <ClassifiedConditionList TraitSetID="93874">
          <ClassifiedCondition>NAXD-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-02-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-02-13" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2019-02-18" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30576410</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31755961</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32462209</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="46379" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41365" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">NAD(P)HX dehydratase deficiency</ElementValue>
                <XRef ID="MONDO:0034121" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 2</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PEBEL2</ElementValue>
                <XRef Type="MIM" ID="618321" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17990" />
                <XRef ID="17990" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="555402" DB="Orphanet" />
              <XRef ID="C5193026" DB="MedGen" />
              <XRef ID="MONDO:0034121" DB="MONDO" />
              <XRef Type="MIM" ID="618321" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="93874" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="74644" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NAXD-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">NAXD-related disorder</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1728604" SubmissionDate="2020-09-16" DateLastUpdated="2020-09-19" DateCreated="2019-02-18">
        <ClinVarSubmissionID localKey="615910.0005_ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2" title="NAXD, 4-BP DEL, 51AGAA_ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2" />
        <ClinVarAccession Accession="SCV000882836" DateUpdated="2020-09-19" DateCreated="2019-02-18" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 1-year-old girl (patient 3) with early-onset progressive encephalopathy with brain edema and/or leukoencephalopathy-2 (PEBEL2; 618321), Van Bergen et al. (2019) identified a homozygous 4-bp deletion (c.51_54delAGAA, NM_01242882.1) in exon 2 of in the NAXD gene, predicted to result in a frameshift and premature termination (Ala20PhefsTer9). The mutation, which was found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. The variant was found in heterozygous state at a low frequency in the gnomAD database (4.47 x 10(-5)).</Attribute>
              <Citation>
                <ID Source="PubMed">30576410</ID>
              </Citation>
              <XRef DB="OMIM" ID="618321" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 7-year-old boy with PEBEL2, Borna et al. (2020) identified compound heterozygous mutations in the NAXD gene: c.51_54delAGAA and a 1-bp deletion (c.44delG; 615910.0006) predicted to result in a frameshift and premature termination (Arg15GlnfsTer3). The mutations, which were found by whole-exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Both mutations are located in the mitochondria-targeted isoform of NAXD. The c.44delG mutation was not found in the dbSNP, gnomAD, or 3.5KJPN database. Overexpression of the either mutation in HEK293FT cells showed loss of protein expression.</Attribute>
              <Citation>
                <ID Source="PubMed">32462209</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <Name>NAXD, 4-BP DEL, 51AGAA</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DEL, 51AGAA</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="615910.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7575506" SubmissionDate="2023-10-19" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="20200135260" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004047087" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="Neuberg Centre For Genomic Medicine, NCGM" OrgID="508108" OrganizationCategory="laboratory" OrgAbbreviation="NCGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The frameshift variant c.108_111del (p.Ala38PhefsTer9) has been reported previously in homozygous state in patients affected with NAXD deficiency (Van Bergen NJ. et al., 2019). This variant is reported with the allele frequency (0.004%) in the gnomAD and novel in 1000 genome database. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000707" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0002376" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001251" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001252" />
              </Trait>
              <Comment>Consanguinity: Present Clinical symptoms: Gross motor delay (lower&gt;upper limbs), started walking at 1.5 years, episodic regression with febrile illness. Investigations done: NCV test- Normal Lactate- High Family history: Probandâ€™s elder sibling was noted to have a similar condition and succumbed to the illness. Clinical suspicion: Metabolic and mitochondrial myopathy</Comment>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018210.4:c.108_111del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618321" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13901154</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8864980" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="13238297|NAXD-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004780230" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-02-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The NAXD c.108_111delAAGA variant is predicted to result in a frameshift and premature protein termination (p.Ala38Phefs*9). This variant has been associated with NAD(P)HX dehydratase (NAXD) deficiency (reported as c.54_57delAAGA using another transcript in Van Bergen et al. 2019. PubMed ID: 30576410). This variant is reported in 0.0086% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in NAXD are expected to be pathogenic. This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018210.3:c.108_111delAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NAXD-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4023795" SubmissionDate="2022-01-04" DateLastUpdated="2022-01-08" DateCreated="2022-01-08">
        <ClinVarSubmissionID localKey="NM_001242881.2:c.108_111del|OMIM:618321" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002053753" DateUpdated="2022-01-08" DateCreated="2022-01-08" Type="SCV" Version="1" SubmitterName="Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India" OrgID="505991" OrganizationCategory="laboratory" OrgAbbreviation="KMC-MAHE" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001242881.2:c.108_111del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="618321" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10900200</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5414541" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_001242882_1_NAXD_c_54_57delAAGA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002769388" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-10-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30576410</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31755961</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32462209</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (exon 2 of 10). (P) 0251 - Variant is heterozygous. (N) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (v2: 12 heterozygotes, 0 homozygotes). (P) 0703 - Comparable variants have moderate previous evidence for pathogenicity. Other variants predicted to cause NMD have been reported as pathogenic (PMID: 31755961, 32462209). (P) 0802 - Moderate previous evidence of pathogenicity in unrelated individuals. This variant has been previously reported in patients with neurodegenerative disorder exacerbated by febrile illnesses. (ClinVar, PMID: 30576410, 32462209). (P) 1002 - Moderate functional evidence supporting abnormal protein function. Functional studies show that this variant causes impaired localisation of protein (PMID: 32462209). (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_4790</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_001242882.1:c.54_57delAAGA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0034121" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4142727" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="2478139|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002123001" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">32462209</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30576410</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32462209</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30576410</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32462209</ID>
          </Citation>
          <Comment>This variant is present in population databases (rs773887880, gnomAD 0.01%). For these reasons, this variant has been classified as Pathogenic. Studies have shown that this premature translational stop signal alters NAXD gene expression (PMID: 32462209). ClinVar contains an entry for this variant (Variation ID: 617759). This variant is also known as c.51_54delAGAA (p.Ala20Phefs*9). This premature translational stop signal has been observed in individuals with clinical features of progressive encephalopathy with brain edema and leukoencephalopathy (PMID: 30576410, 32462209). This sequence change creates a premature translational stop signal (p.Ala38Phefs*9) in the NAXD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NAXD are known to be pathogenic (PMID: 30576410, 32462209).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="NAXD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.111274567_111274570del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9861793" SubmissionDate="2024-07-17" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="GDXSV:482832" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005080461" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Published functional studies demonstrate a loss of protein expression (Borna et al., 2020); This variant is associated with the following publications: (PMID: 32462209, 30576410)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CARKD" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:4293451</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_018210.3:c.108_111del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_313_20240717054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7575506" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000707" MappingRef="HP">
        <MedGen CUI="C0497552" Name="Abnormality of the nervous system" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575506" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001251" MappingRef="HP">
        <MedGen CUI="C0007758" Name="Cerebellar ataxia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4023795" TraitType="Disease" MappingType="XRef" MappingValue="618321" MappingRef="OMIM">
        <MedGen CUI="C5193026" Name="NAD(P)HX dehydratase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9861793" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575506" TraitType="Finding" MappingType="XRef" MappingValue="HP:0002376" MappingRef="HP">
        <MedGen CUI="C1836830" Name="Developmental regression" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8864980" TraitType="Disease" MappingType="Name" MappingValue="NAXD-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="NAXD-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4142727" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575506" TraitType="Disease" MappingType="XRef" MappingValue="618321" MappingRef="OMIM">
        <MedGen CUI="C5193026" Name="NAD(P)HX dehydratase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7575506" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001252" MappingRef="HP">
        <MedGen CUI="C0026827" Name="Hypotonia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1728604" TraitType="Disease" MappingType="Name" MappingValue="ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2" MappingRef="Preferred">
        <MedGen CUI="C5193026" Name="NAD(P)HX dehydratase deficiency" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5414541" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0034121" MappingRef="MONDO">
        <MedGen CUI="C5193026" Name="NAD(P)HX dehydratase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

